423,443 Registered Patient Population |
3.24% of Total Population Represented by Patients |
166 Total Medical Retail Locations Currently in Operation |
255,086 : 1 Patients : Retail |
Navigating Pennsylvania State Laws:
Patients and Caregivers: Enrolling and Accessing Medical Cannabis
Medical Professionals: Procedures for recommending Medical Cannabis
Policymakers and Advocates: Actions Needed to Improve Laws for Patients
NOTICE: It can be challenging for patients to determine which businesses offering cannabis products are licensed and approved by the state. Review this list of medical cannabis retailers to find out where to purchase regulated cannabis in Pennsylvania.
Traveling? Get more information about traveling in the US here.
Get involved locally!
Background on State Laws
Medical Cannabis is legal in Pennsylvania, however home cultivation is not. Patients and caregivers may purchase up to a 30 day supply from dispensaries. Pennsylvania does not recognize out of state medical cannabis cards. Patients report few dispensaries and high prices as barriers to access. As a patient, you will have an affirmative defense in court if you are arrested for cannabis possession. You will also be legally protected from discrimination based on your cannabis use in a child custody hearing. An employer will not be allowed to fire you on the basis of your enrollment in the program. In 2018, the Department of Health also announced in 2018 that it will not share patient registry information with law enforcement agencies, a move designed to maintain legal firearm ownership rights for medical cannabis patients. Other states do not provide this layer of protection, leaving those patients who own firearms vulnerable to second amendment rights infringements due to the conflict of federal and state cannabis laws. Details on how these laws apply to patients and medical professionals can be found below.
Here is a breakdown of how Pennsylavnia fared in ASA’s Annual State of the States Report, which evaluates the effectiveness of each state cannabis program from a patient perspective and assigns a grade using a rubric that reflects the key issues affecting patient access. Medical cannabis laws are constantly changing, ASA’s policy recommendations for Pennsylvania can be found below. For policy updates Sign Up here or Take Action!
Patient Rights and Civil Protections |
70/100 |
|
Arrest Protection |
25/25 |
Affirmative Defense |
10/20 |
Parental Rights Protections |
20/20 |
DUI Protections |
0/10 |
Employment Protections |
10/20 |
Explicit Privacy Standards |
5/5 |
|
Access to Medicine |
50/100 |
|
Authorizes Retail Access |
10/10 |
Alternative Accessibility Methods |
15/20 |
- Authorizes Delivery |
5/10 |
- Authorizes Curbside Pickup |
10/10 |
Personal Cultivation |
0/15 |
Collective Gardening |
0/5 |
Sufficient Number of Licensed Retailers |
25/30 |
Reciprocity |
0/20 |
|
Program Functionality |
91/100 |
|
Legal Protections Within Reasonable Time Frame |
14/20 |
Reasonable Possession Limits |
10/10 |
Reasonable Purchase Limits |
10/10 |
Telemedicine for Physician Certifications |
15/15 |
Patient and Physician Representation in Program Decision Making |
20/20 |
Reasonable Caregiver Standards |
4/5 |
- Background Checks |
1/2 |
- Number of Caregivers |
3/3 |
Reasonable Physician Standards |
3/5 |
Access to Administration Methods |
10/10 |
- Allows Dried Flower |
5/5 |
- Allows Edibles, Concentrates, and Other Forms |
5/5 |
Provides Access to Minors on School Grounds |
5/5 |
|
Affordability |
58/100 |
|
Sales Tax Break for Patients and Caregivers |
20/20 |
Covered by State Insurance or Health Aid |
0/20 |
Reasonable Registration Fees |
18/20 |
Financial Hardship Waivers or Discounts |
20/20 |
Donation Program |
0/10 |
Allows Multi-Year Registrations |
0/10 |
|
Health and Social Equity |
43/100 |
|
State Program Protections |
20/25 |
Housing Protections |
0/25 |
Access for Minors |
10/10 |
Access in Underserved Areas |
4/10 |
List of Qualifying Conditions is Exhaustive or All Inclusive |
9/10 |
Allows Patients to Medicate Where they Choose |
0/10 |
Organ Transplants |
0/5 |
Ownership or Employment Restrictions |
0/5 |
|
Consumer Protection and Product Safety |
165/200 |
|
Cultivation Operations |
40/50 |
Quality Management Systems |
5/10 |
Staff Training |
10/10 |
Standard Operating Procedures |
7/8 |
- Facility and Equipment Sanitation |
1/1 |
- Workplace Safety |
1/1 |
- Storage |
1/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
1/1 |
- Water Management |
0/1 |
- Records Management |
1/1 |
Pesticide Usage Limitations |
1/2 |
Environmental Impact Regulations |
1/2 |
Required Testing |
8/8 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Microbials |
1/1 |
- Aflatoxins |
1/1 |
- Pesticides |
1/1 |
- Heavy Metals |
1/1 |
- Foreign Matter |
1/1 |
- Moisture Content/ Water Activity |
1/1 |
Packaging and Labeling |
1/3 |
- Cannabinoids |
1/1 |
- Terpenes |
0/1 |
- Pesticides |
0/1 |
Complaints, Adverse Event Reporting, and Recall Protocol |
7/7 |
Manufacturing Operations |
37/50 |
Quality Management Systems |
5/10 |
Staff Training |
10/10 |
Standard Operating Procedures |
7/7 |
- Facility and Equipment Sanitation |
1/1 |
- Workplace Safety |
1/1 |
- Storage |
1/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
1/1 |
- Records Management |
1/1 |
Environmental Impact Regulations |
0/3 |
Required Testing |
9/10 |
- Cannabinoids |
1/1 |
- Terpenes |
1/1 |
- Microbials |
1/1 |
- Aflatoxins |
1/1 |
- Pesticides |
1/1 |
- Heavy Metals |
1/1 |
- Residual Solvents |
1/1 |
- Homogeneity |
0/1 |
- Foreign Matter |
1/1 |
- Water Activity |
1/1 |
Packaging and Labeling |
1/5 |
- Cannabinoids |
1/1 |
- Terpenes |
0/1 |
- Ingredients |
0/1 |
- Allergens |
0/1 |
- Nutritional Content |
0/1 |
Complaints, Adverse Event Reporting and Recall Protocol |
5/5 |
Dispensary Operations |
40/50 |
Staff Training |
20/20 |
Standard Operating Procedures |
7/7 |
- Facility Sanitation |
1/1 |
- Workplace Safety |
1/1 |
- Storage |
1/1 |
- Batch and Lot Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
1/1 |
- Records Management |
1/1 |
Product Testing |
0/10 |
- Product Meets Requirements Before Sale |
0/5 |
- COA Disclosure |
0/5 |
Complaints, Adverse Event Reporting and Recall Protocol |
13/13 |
Laboratory Operations |
48/50 |
Independent or Third-Party |
5/5 |
Laboratory Sampling |
5/5 |
Method Validation |
4/4 |
Quality Management Systems |
4/5 |
Staff Training |
20/20 |
Standard Operating Procedures |
6/7 |
- Facility and Equipment Sanitation |
0/1 |
- Equipment and Instrument Calibration |
1/1 |
- Workplace Safety |
1/1 |
- Sample Tracking |
1/1 |
- Security |
1/1 |
- Waste Disposal |
1/1 |
- Records Management |
1/1 |
Result Reporting |
4/4 |
|
Score Penalties |
15/95 |
|
Gives Regulatory Preference to Adult Use |
0/20 |
Classifies Cannabis as a Medicine of Last Resort |
0/15 |
Administrative or Supply Problems |
0/10 |
Requires Vertical Integration |
5/10 |
Creates New Criminal Penalties for Patients |
10/10 |
Limits Patients to a Single Retailer |
0/10 |
No System for Adding Qualifying Conditions |
0/10 |
Imposes Bans or Limits on THC |
0/5 |
Imposes Bans or Limits on CBD |
0/5 |
|
Excerpted from ASA's 2022 State of the States Report. |